TickerFacts.

Exagen Inc. (XGN): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$11.97M
Year ended 2025-12-31
-$10.81M
Trailing 12 months to 2026-06-30
2018-12-31: -$4.28M2019-12-31: -$8.70M2020-12-31: -$14.69M2021-12-31: -$23.17M2022-12-31: -$44.45M2023-12-31: -$20.64M2024-12-31: -$11.94M2025-12-31: -$11.97M-$11.97M
2018-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$11.97Mn/m2026-03-10, From 2025-01-01
2024-12-31-$11.94Mn/m2026-03-10, From 2024-01-01
2023-12-31-$20.64Mn/m2025-03-11, From 2023-01-01
2022-12-31-$44.45Mn/m2024-03-18, From 2022-01-01
2021-12-31-$23.17Mn/m2023-03-20, From 2021-01-01
2020-12-31-$14.69Mn/m2022-03-22, From 2020-01-01
2019-12-31-$8.70Mn/m2021-03-16, From 2019-01-01
2018-12-31-$4.28Mn/a2020-03-25, From 2018-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Exagen Inc. (XGN)2025-12-31-$11.97Mn/m
Personalis, Inc. (PSNL)2025-12-31-$78.01Mn/m
Biodesix Inc (BDSX)2025-12-31-$22.20Mn/m
American Shared Hospital Services (AMS)2025-12-31$2.13M-36.9%
BillionToOne, Inc. (BLLN)2025-12-31$22.92Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$66.97Mn/m
Castle Biosciences Inc (CSTL)2025-12-31-$2.04Mn/m
CareDx, Inc. (CDNA)2025-12-31-$15.76Mn/m
Veracyte, Inc. (VCYT)2025-12-31$79.19M+100.0%

Compare XGN, PSNL, BDSX, AMS side by side · Screen every company in Services-Medical Laboratories ↗